yttrium Y 90 anti-CD45 monoclonal antibody AHN-12
Term · Oncology and biomedicine · MLC-T-ONC-017622
A radioimmunoconjugate comprised of the monoclonal antibody AHN-12 conjugated to the radioisotope yttrium 90 with potential radioimmunotherapeutic activity. Yttrium Y 90 monoclonal antibody AHN-12 binds to the tyrosine phosphatase CD45, expressed on the surface of normal and malignant hematopoietic cells. After binding and internalization by CD45-expressing tumor cells, this agent may deliver a cytotoxic dose of beta radiation.
| Identifier | MLC-T-ONC-017622 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | Y 90 AHN-12 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017622",
"term": "yttrium Y 90 anti-CD45 monoclonal antibody AHN-12",
"field": "Oncology and biomedicine",
"definition": "A radioimmunoconjugate comprised of the monoclonal antibody AHN-12 conjugated to the radioisotope yttrium 90 with potential radioimmunotherapeutic activity. Yttrium Y 90 monoclonal antibody AHN-12 binds to the tyrosine phosphatase CD45, expressed on the surface of normal and malignant hematopoietic cells. After binding and internalization by CD45-expressing tumor cells, this agent may deliver a cytotoxic dose of beta radiation.",
"abbreviation": "Y 90 AHN-12",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/yttrium-y-90-anti-cd45-monoclonal-antibody-ahn-12/"
}
Record 17,557 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.